Envestnet Asset Management
CVS icon

Envestnet Asset Management’s CVS Health CVS Stock Holding History

Envestnet Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300M Buy
2,902,944
+982,034
+51% +$87.7M 0.07% 251
2026
Q1 		$138M Buy
1,920,910
+53,252
+3% +$4.1M 0.04% 431
2025
Q4 		$148M Sell
1,867,658
-123,244
-6% -$9.72M 0.04% 383
2025
Q3 		$150M Buy
1,990,902
+51,076
+3% +$3.5M 0.04% 388
2025
Q2 		$134M Buy
1,939,826
+76,748
+4% +$5.03M 0.04% 411
2025
Q1 		$126M Buy
1,863,078
+333,364
+22% +$19.9M 0.04% 391
2024
Q4 		$68.7M Buy
1,529,714
+15,561
+1% +$873K 0.02% 584
2024
Q3 		$95.2M Sell
1,514,153
-406,178
-21% -$23.7M 0.03% 485
2024
Q2 		$113M Sell
1,920,331
-1,590,414
-45% -$99.5M 0.04% 411
2024
Q1 		$280M Buy
3,510,745
+954,019
+37% +$72.9M 0.1% 188
2023
Q4 		$202M Sell
2,556,726
-35,782
-1% -$2.55M 0.08% 228
2023
Q3 		$181M Buy
2,592,508
+347,939
+16% +$24.7M 0.08% 238
2023
Q2 		$155M Sell
2,244,569
-113,994
-5% -$8.11M 0.07% 245
2023
Q1 		$175M Sell
2,358,563
-166,981
-7% -$14M 0.08% 210
2022
Q4 		$235M Buy
2,525,544
+115,226
+5% +$11.1M 0.12% 156
2022
Q3 		$230M Buy
2,410,318
+97,170
+4% +$9.62M 0.13% 136
2022
Q2 		$214M Buy
2,313,148
+95,978
+4% +$9.37M 0.12% 157
2022
Q1 		$224M Buy
2,217,170
+15,331
+0.7% +$1.61M 0.11% 163
2021
Q4 		$227M Buy
2,201,839
+78,296
+4% +$7.24M 0.11% 161
2021
Q3 		$180M Buy
2,123,543
+52,239
+3% +$4.38M 0.1% 179
2021
Q2 		$173M Sell
2,071,304
-18,656
-0.9% -$1.53M 0.1% 181
2021
Q1 		$157M Buy
2,089,960
+831,506
+66% +$60.6M 0.1% 168
2020
Q4 		$86M Buy
1,258,454
+134,418
+12% +$8.74M 0.06% 229
2020
Q3 		$65.6M Sell
1,124,036
-61,229
-5% -$3.81M 0.06% 252
2020
Q2 		$77M Buy
1,185,265
+136,905
+13% +$8.62M 0.08% 210
2020
Q1 		$62.2M Buy
1,048,360
+88,754
+9% +$5.92M 0.07% 208
2019
Q4 		$71.3M Buy
959,606
+58,608
+7% +$4.12M 0.08% 197
2019
Q3 		$56.8M Buy
900,998
+28,192
+3% +$1.67M 0.06% 237
2019
Q2 		$47.6M Buy
872,806
+71,496
+9% +$3.85M 0.06% 240
2019
Q1 		$43.2M Sell
801,310
-66,996
-8% -$4.14M 0.06% 244
2018
Q4 		$56.9M Buy
868,306
+693,266
+396% +$51.8M 0.09% 169
2018
Q3 		$13.8M Sell
175,040
-40,469
-19% -$2.89M 0.02% 255
2018
Q2 		$13.9M Buy
215,509
+147,741
+218% +$9.74M 0.03% 258
2018
Q1 		$4.21M Sell
67,768
-249,453
-79% -$17.9M 0.01% 445
2017
Q4 		$23M Sell
317,221
-65,190
-17% -$4.74M 0.05% 208
2017
Q3 		$31.1M Sell
382,411
-31,710
-8% -$2.51M 0.07% 138
2017
Q2 		$33.3M Buy
414,121
+10,127
+3% +$800K 0.09% 132
2017
Q1 		$31.7M Buy
403,994
+74,222
+23% +$5.93M 0.1% 135
2016
Q4 		$26M Buy
329,772
+66,521
+25% +$5.38M 0.09% 157
2016
Q3 		$23.4M Sell
263,251
-62,253
-19% -$5.88M 0.09% 170
2016
Q2 		$31.2M Sell
325,504
-6,345
-2% -$632K 0.12% 136
2016
Q1 		$34.4M Sell
331,849
-30,866
-9% -$3M 0.15% 118
2015
Q4 		$35.5M Sell
362,715
-18,068
-5% -$1.77M 0.16% 122
2015
Q3 		$36.7M Buy
380,783
+834
+0.2% +$87.7K 0.18% 104
2015
Q2 		$39.8M Buy
379,949
+19,864
+6% +$2.03M 0.19% 109
2015
Q1 		$37.2M Buy
360,085
+338,842
+1,595% +$34.3M 0.19% 111
2014
Q4 		$2.05M Sell
21,243
-10,501
-33% -$925K 0.02% 374
2014
Q3 		$2.53M Buy
31,744
+1,077
+4% +$84.9K 0.03% 352
2014
Q2 		$2.31M Sell
30,667
-634
-2% -$47.9K 0.02% 350
2014
Q1 		$2.34M Sell
31,301
-568
-2% -$40.1K 0.03% 296
2013
Q4 		$2.28M Sell
31,869
-1,227
-4% -$78.8K 0.03% 289
2013
Q3 		$1.88M Sell
33,096
-11,769
-26% -$701K 0.02% 296
2013
Q2 		$2.56M Buy
+44,865
New +$2.6M 0.03% 244

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Envestnet Asset Management's CVS Position: Q2 2026 in Review

Envestnet Asset Management increased its CVS Health (CVS) stake by 51% in Q2 2026, buying an estimated $87.7M and bringing the position to 2,902,944 shares worth $300M. The position accounts for 0.07% of the portfolio, ranked #251.

Envestnet Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Envestnet Asset Management held 2,902,944 shares of CVS Health worth $300M as of Q2 2026.
  • Envestnet Asset Management bought 982,034 CVS Health shares in Q2 2026, an estimated $87.7M.
  • CVS Health made up 0.07% of Envestnet Asset Management's portfolio in Q2 2026, its #251 holding.
  • Envestnet Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.